Yüklüyor......
Escalation strategies for combination therapy Phase I trials
Phase I clinical trials aim to identify a maximum tolerated dose (MTD), the highest possible dose that does not cause an unacceptable amount of toxicity in the patients. In trials of combination therapies, however, many different dose combinations may have a similar probability of causing a dose-lim...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley & Sons, Ltd
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3573644/ https://ncbi.nlm.nih.gov/pubmed/22411472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1497 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|